HeraMED Limited (FRA:1I4)

Germany · Delayed Price · Currency is EUR

0.0275

+0.0060 (27.91%)

Last updated: Oct 9, 2026, 4:41 PM CET

Market Cap	26.71M +11.9%
Revenue (ttm)	200.09K -24.9%
Net Income	-2.10M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.0275
Previous Close	0.0215
Day's Range	0.0275 - 0.0275
52-Week Range	0.0140 - 0.0335
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 1I4

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial numbers in AUD Financial Statements